Letter | Published:

Epidermal growth factor-dependent phosphorylation of lipocortin

Nature volume 321, pages 8184 (01 May 1986) | Download Citation

Subjects

Abstract

Lipocortin-like proteins are a family of steroid-induced inhibitors of phospholipase activity with potential anti-inflammatory activity (for reviews see refs 1, 2). Related proteins have been detected in a variety of tissues and species3–7. The best characterized form is a protein of relative molecular mass (Mr)40,000 (40K), which is phosphorylated in vivo by protein tyrosine kinases and by protein serine-threonine kinases8,9. It has been proposed that the phospholipase inhibitory activity of lipocortin can be regulated by its phosphorylation5. In the A431 cell line, a protein of 35K is phosphorylated by the protein tyrosine kinase activity of the epidermal growth factor (EGF) receptor10. Here we report that human lipocortin is phosphorylated near its amino terminus by the EGF receptor/kinase. By peptide mapping and immunological analyses, we show that lipocortin and the endogenous 35K substrate for the EGF receptor/kinase from A431 cells are the same protein.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Adv. Inflamm. Res. 7, 61–69 (1984).

  2. 2.

    Adv. Inflamm. Res. 7, 71–78 (1984).

  3. 3.

    et al. Br. J. Pharmac. 76, 185–194 (1982).

  4. 4.

    et al. J. biol. Chem. 261, 4239–4246 (1986).

  5. 5.

    J. biol. Chem. 256, 7730–7733 (1981).

  6. 6.

    , , , & Biochem. biophys. Res. Commun. 117, 878–884 (1983).

  7. 7.

    , , , & Proc. natn. Acad. Sci. U.S.A. 81, 1140–1143 (1984).

  8. 8.

    et al. Biochem. biophys. Res. Commun. 118, 682–690 (1984).

  9. 9.

    , , , & Proc. natn. Acad. Sci. U.S.A. 81, 4717–4721 (1984).

  10. 10.

    & J. biol. Chem. 260, 8233–8236 (1985).

  11. 11.

    et al. Nature 320, 77–81 (1986).

  12. 12.

    & J. biol. Chem. 255, 8363–8365 (1980).

  13. 13.

    , , & J. biol. Chem. 257, 1523–1531 (1982).

  14. 14.

    , & Biochemistry 19, 1524–1528 (1980).

  15. 15.

    & J. biol. Chem. 259, 2636–2645 (1984).

  16. 16.

    , & Proc. natn. Acad. Sci. U.S.A. 74, 565–569 (1977).

  17. 17.

    & Analyt. Biochem. 48, 153–163 (1972).

  18. 18.

    J. biol. Chem. 258, 11229–11235 (1983).

  19. 19.

    & J. Virol. 52, 145–153 (1984).

  20. 20.

    , & Meth. Enzym. 99, 387–402 (1983).

  21. 21.

    & Proc. natn. Acad. Sci. U.S.A. 82, 7884–7888 (1985).

  22. 22.

    , & Proc. natn. Acad. Sci. U.S.A. 83, 236–240 (1986).

  23. 23.

    & J. biol. Chem. 260, 1688–1695 (1985).

  24. 24.

    & Cell 21, 829–836 (1980).

  25. 25.

    Nature 227, 680–685 (1970).

  26. 26.

    , , & Analyt. Biochem. 118, 197–203 (1981).

Download references

Author information

Affiliations

  1. Biogen Research Corporation, 14 Cambridge Center, Cambridge, Massachusetts 02142, USA

    • R. Blake Pepinsky
    •  & Lesley K. Sinclair

Authors

  1. Search for R. Blake Pepinsky in:

  2. Search for Lesley K. Sinclair in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/321081a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.